Hospira said it has been working with Food and Drug Administration regulators on its quality issues, which have negatively impacted the company’s sales in the last year.
According to the report, Hospira reported a stronger-than-expected 6 percent profit increase in the first quarter. Net income rose to $149.9 million, or 88 cents a share, from $141.7 million, or 84 cents a share, a year earlier.
Read the Chicago Tribune report on Hospira.
Related Articles on Drug Shortages:
American Society of Anesthesiologists Conducts Survey on Drug Shortages
6 Strategies for Surgery Centers to Address Drug Shortages
Sen. Blumenthal Requests GAO Investigation of Drug Shortages
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
